Article
Enantioselectivity of debrisoquine 4-hydroxylation in Brazilian Caucasian hypertensive patients phenotyped as extensive metabolizers.
Journal of chromatography. B, Biomedical sciences and applications - 1 Dec 2000
Cerqueira P M, Mateus F H, Cesarino E J, Bonato P S, Lanchote V L
Abstract excerpt
Debrisoquine (D), an antihypertensive drug metabolized to 4-hydroxydebrisoquine (4-OHD) by CYP2D6, is commonly used as an in vivo probe of CYP2D6 activity and can be used to phenotype individuals as either extensive (EMs) or poor metabolizers (PMs) of such drugs as beta-adrenergic blockers, tricyclic antidepressants, and class 1C antiarrhythmics. This report describes reversed-phase HPLC systems by which D and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
